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Abstract
Introduction: Pregnancy in patients with end-stage renal disease is rare due to numerous factors
that impair fertility. Even if pregnancy does occur pregnancy outcome with a live birth has a low
success rate.
Case presentation: We report two cases of successful pregnancy in patients with end-stage renal
disease on hemodialysis.
Conclusion: The purpose of hemodialysis is not only to maintain life but also to make quality of life
as normal as possible for the end-stage renal disease patient. Propagation of life is basic to all life
forms and the ability to do so can be considered as a success in a patient with end-stage renal disease.
Introduction
Pregnancy in patients with advanced chronic kidney disease
andpatientswithend-stagerenaldisease(ESRD)israre,due
to a multiple factors. We present two cases: a 33-year-old
AfricanAmericanfemaleanda28-year-oldAfricanAmerican
female whose pregnancies were successfully managed.
Management of these patients requires a multi-disciplin-
ary team approach - including obstetrician, hemodialysis
or peritoneal dialysis unit staff, renal dietitian,
nephrologists.
Case presentation
Case report 1
A 33-year-old African American female, gravida 4, with no
abortions in the past and three living offspring, other
medical problems included hypothyroidism. Etiology of
ESRD was felt to be hypertensive nephrosclerosis second-
ary to poorly controlled hypertension. The patient had
initiated hemodialysis in March 2004 and was receiving
three times a week maintenance HD with no significant
problems. Vascular access was a right internal jugular
tunneled catheter. Six months after initiating hemodialy-
sis, patient reported approximately 6 weeks of amenor-
rhea. She was found to be pregnant after measurement of
serum HCG and pelvic ultrasound.
Hemodialysis prescription was changed to 6 days a week,
three and a half hour per treatment. Dietary regime was
liberalized in regards to protein consumption; serum
albumin was maintained between 3.8-4 g/dl. Weekly Kt/V
was maintained at a value between 6-8. (Kt/V is defined as
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manufacturer in ml/min, multiplied by the duration of the
dialysis treatment (t, in minutes) divided by the volume of
distribution of urea in the body (V, in ml)). She also
received multivitamin and folic acid throughout the
pregnancy. Hypertension remained a concern during this
period, she was on an ACE-inhibitor prior to the
pregnancy, this had to be discontinued, and she was
treated with a regimen of hydralazine, labetalol, and alpha
methyl dopa. Her BP averaged 110-140/70-90. Patient’s
hemoglobin was maintained between 9-11 with use of
Epogen administered three times a week, she was also
given iron supplementation to maintain iron saturation of
20% or greater per the hemodialysis unit’s anemia and
iron protocol.
Caesarean section was performed at 27
3/7 weeks of
gestation for non reassuring fetal status and malpresenta-
tion (transverse lie). She delivered a 1 pound 14 ounce
female infant with an uneventful neonatal period. A year
after, both mother and infant were in excellent condition.
Case report 2
A 28-year-old black female with one living offspring and
no abortions with past medical history of polycystic
kidney disease, HTN, anemia of chronic disease and goiter.
The patient had progressed to Chronic Kidney Disease
Stage V and it was recommended that she initiate
hemodialysis, however she had been refusing hemodia-
lysis. She presented with abdominal distension and
amenorrhea was found to be 12 weeks pregnant,
diagnosed by serum HCG testing and pelvic ultrasound.
Patient agreed to undergo hemodialysis once pregnancy
was confirmed. Folate and Iron supplementation was
started. Hemodialysis was initiated via tunneled dialysis
catheter, 6 days a week, with each session 3 hours and 15
minutes duration. Weekly Kt/V was maintained at a value
between 6-8. Dietary regime also was liberalized in regards
to protein intake; serum albumin was maintained between
3.8-4 g/dl. Epogen was administered to maintain hemo-
globin between 10-11 mg/dl. Iron supplementation was
used to maintain iron saturation of 30% or greater per the
hemodialysis unit’s anemia and iron protocol. BP was
maintained between 110-140/70-80 mmHg using amlo-
dipine, alpha-methyldopa, and labetalol. Patient was also
administered oral multivitamins and folic acid.
At 29 weeks the obstetric team found that the fetal growth
was lagging behind and the Doppler studies of the
umbilical arteries were abnormal. Contraction stress test
was found to be positive and she was delivered by
Caesarean section resulting in a single viable female child
weighing one and a half pound with an uneventful
neonatal period. Patient and child remain healthy one
year after.
Discussion
In 1971 Confortini et al. [1] reported the 1st successful
pregnancy in a 35 year old woman on chronic
hemodialysis.
The largest study ‘Registry of pregnancy in dialysis patients’
showed 2% of patients on dialysis became pregnant over a
4-year period [2].The estimated frequency of conception in
patients on dialysis is within a range as variable as 1.4%
per year in Saudi Arabia to 0.5% in USA [3].
The reduced fertility is due to anovulation and hyperpro-
lactinemia leading to oligomenorrhoea seen in female
patients on dialysis [4]. Other factors that contribute are
reduced libido due to altered human chorionic gonado-
tropin pulses and reduced renal leptin clearance [5,6].
Leptin levels are known to be high in obese women as well
and may be a contributory factor to the infertility observed
in them. Leptin has been shown to affect the hypotha-
lamic-pituitary axis through neuropeptide Y and high
affinity binding sites have been detected in the
hypothalamus.
Even if pregnancy does occur in a patient with chronic
kidney disease a study done in Japan [7] showed that it
resulted in spontaneous abortion in 56% of patients, 11%
developed still births, 14% had neonatal deaths, 18% had
therapeutic abortion, approximately 40% abortions
occurred in 2
nd trimester.
The outcome of pregnancies in such patients has markedly
improved from approximately 20% live births during the
1980s [8] to 85% surviving infants according to case report
published in Turkey in 2004 [9]. It has been shown that
that the prognosis for successful conclusion of pregnancy
is better for patients who begin dialysis after the onset of
pregnancy as compared to patients who are already on
dialysis (72.6% and 37.5%), respectively [2]. Our article
reports cases representing both these groups.
An increase dose of dialysis with a weekly Kt/V of 6-8 or
dialysis 5-6 days/week is considered beneficial [10]. We
were also dialyzing both patients 6 days a week.
In 1997 recommendations had been published for the
most appropriate treatment for patients on dialysis [4]
listed in Table 1. These were the basis for treatment in both
patients.
Conclusion
Women on dialysis who wish to conceive or continue their
existing pregnancies should be given special antenatal and
neonatal care. Joint efforts of nephrologists, dialysis unit
staff, nutritionists and obstetricians can help to make the
pregnancy successful. Careful attention need to be paid to
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Cases Journal 2009, 2:8139 http://casesjournal.com/casesjournal/article/view/8139dialysis strategy, anemia control, fluid balance, control of
hypertension and nutrition. It is appropriate that these
patients should be managed in a high risk pregnancy
facility including a neonatal intensive care unit. In patients
who have already completed their family contraception
should be advised as pregnancy can occur even after many
years of being on dialysis.
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Table 1. Recommendations for treatment of patients on dialysis
1. Dialysis regime must maintain blood urea levels at 17 mmol/L
(102.4 mg/dl).
2. If treating with hemodialysis, 5-7 sessions per week should be carried
out, with minimum heparinization and low ranges of ultrafiltration.
3. If treating with peritoneal dialysis, reduce the volumes of dialysis
solution (1.5 L) and increase the frequency.
4. Adapt the amount of calories and proteins: protein ingestion: 1 g/kg/day,
adding 20 g/day for fetal growth. Add supplements of water-soluble
vitamins and zinc.
5. Treatment of hypertension must be done under strict supervision and
with pharmacological adaptation.
6. Correct anemia based on guidelines for the management of anemia in
renal disease patients as per NKF-DOQI guidelines, reinforcing therapy
with erythropoietin (compatible with proper blood pressure control)
to keep hemoglobin above 10 g/dl and transferrin saturation above 30%.
7. Prevent metabolic acidosis.
8. Manage mineral metabolism; avoid hypo- and hypercalcemia.
9. Prevent hypomagnesemia with adequate dialysis baths and eventually
with oral supplements.
10. Treat premature start of labor with beta-agonists and magnesium
sulfate. Reinforce fetal monitoring, especially during hemodialysis
sessions.
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